Estradiol
HormonesWhat is Estradiol?
Estradiol (E2) is the most potent and abundant form of estrogen, the primary female sex hormone. It is one of three naturally occurring estrogens in the body (estradiol, estrone, and estriol), and is responsible for the majority of estrogen's physiological effects. In premenopausal women, estradiol is primarily produced by the ovarian follicles and the corpus luteum. In men and postmenopausal women, smaller amounts are produced through the conversion of testosterone by the enzyme aromatase in fat tissue, bone, brain, and other organs. Estradiol is critical for the development and maintenance of female reproductive organs, breast tissue, bone density, cardiovascular health, brain function, and skin integrity.
Estradiol levels fluctuate significantly throughout the menstrual cycle, rising during the follicular phase, peaking just before ovulation (triggering the LH surge), and rising again during the luteal phase before declining if pregnancy does not occur. During pregnancy, estradiol levels increase dramatically. After menopause, estradiol levels drop substantially to levels similar to or lower than those seen in men. Estradiol is measured via a blood test and results must be interpreted in the context of menstrual cycle timing, menopausal status, and whether fertility treatments are being administered.
Why It Matters
Estradiol is essential for female reproductive health, bone metabolism, cardiovascular protection, and brain function. In premenopausal women, estradiol deficiency causes menstrual irregularities, infertility, and accelerated bone loss. The dramatic decline in estradiol at menopause is responsible for hot flashes, vaginal dryness, mood changes, and the accelerated bone loss that leads to postmenopausal osteoporosis. In men, estradiol is important for bone health and libido, but excess estradiol can cause gynecomastia (breast tissue enlargement). Estradiol monitoring is also essential during fertility treatments and hormone replacement therapy.
Normal Reference Ranges
| Group | Range | Unit |
|---|---|---|
| Premenopausal Women (follicular) | 12.5–166 | pg/mL |
| Premenopausal Women (ovulatory peak) | 85–498 | pg/mL |
| Postmenopausal Women | <6–54 | pg/mL |
| Adult Men | 7.6–42.6 | pg/mL |
Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.
What High E2 Levels Mean
Common Causes
- Ovarian hyperstimulation during fertility treatments
- Estrogen-producing ovarian tumors (granulosa cell tumors)
- Obesity (increased aromatase activity in adipose tissue)
- Liver disease (impaired estrogen metabolism)
- Exogenous estrogen therapy or hormone replacement
- Gynecomastia-causing conditions in men
- Early puberty (precocious puberty)
Possible Symptoms
- Breast tenderness and swelling
- Bloating and water retention
- Mood swings, anxiety, and irritability
- Heavy or irregular menstrual periods
- Headaches and migraines
- Gynecomastia (breast tissue growth) in men
- Weight gain, particularly in hips and thighs
- Increased risk of blood clots with exogenous estrogen
What to do: High estradiol should be evaluated in clinical context. In premenopausal women, consider timing within the menstrual cycle and rule out pregnancy. Persistently elevated estradiol outside of ovulation warrants ovarian ultrasound to evaluate for estrogen-producing tumors. In men, elevated estradiol with gynecomastia should prompt evaluation for obesity, liver disease, testicular tumors, and medications. Aromatase inhibitors (such as anastrozole or letrozole) may be used in specific clinical situations. During fertility treatments, estradiol is closely monitored to adjust medication dosing and prevent ovarian hyperstimulation syndrome.
What Low E2 Levels Mean
Common Causes
- Menopause (natural, surgical, or premature ovarian insufficiency)
- Hypothalamic amenorrhea (from excessive exercise, low body weight, or stress)
- Polycystic ovary syndrome (some presentations)
- Hypopituitarism
- Turner syndrome
- Chemotherapy or radiation to the ovaries
- Aromatase inhibitor therapy (breast cancer treatment)
Possible Symptoms
- Hot flashes and night sweats
- Vaginal dryness and painful intercourse
- Irregular or absent menstrual periods
- Mood changes, depression, and difficulty concentrating
- Decreased bone density (osteopenia or osteoporosis)
- Dry skin and thinning hair
- Joint pain and stiffness
- Increased urinary tract infections
What to do: Low estradiol in premenopausal women should be evaluated with FSH and LH to determine whether the cause is ovarian (primary—elevated FSH) or central (secondary—low FSH/LH). In women with amenorrhea, pregnancy should always be excluded first. Hypothalamic amenorrhea often responds to restoring adequate caloric intake and reducing excessive exercise. For menopausal symptoms, hormone replacement therapy (HRT) with estradiol can effectively treat hot flashes, vaginal dryness, and bone loss, though risks and benefits must be individualized. DEXA bone density scanning should be considered in women with prolonged estrogen deficiency.
When Is E2 Testing Recommended?
- When evaluating menstrual irregularities, amenorrhea, or infertility in women
- When assessing menopausal symptoms and considering hormone replacement therapy
- When monitoring ovarian stimulation during fertility treatments (IVF/IUI)
- When evaluating gynecomastia or suspected estrogen excess in men
Frequently Asked Questions
Related Biomarkers
Want your E2 levels analyzed?
Upload your lab results for an instant AI-powered breakdown of all your biomarkers.
Upload Lab Results →Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.